Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
D000307:Adrenal Gland Diseases / Q000139:chemically induced; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000616:Aminoglutethimide / Q000009:adverse effects / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use*; D008875:Middle Aged; D010910:Pituitary Irradiation; D011537:Pruritus / Q000139:chemically induced; D011565:Psoriasis / Q000139:chemically induced; D011882:Radiotherapy, High-Energy
D000616:Aminoglutethimide; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D008797:Metyrapone